A Phase 1, Open-Label Study to Assess the Absolute Bioavailability of a Single Oral Dose of Lesinurad With Respect to an Intravenous Micro Tracer Dose of [14C]Lesinurad in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2014
Price : $35 *
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 16 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Mar 2014.
- 04 Mar 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.